South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd.
VUNO, a member company of the Born2Global Centre, announced that their AI based screening solution for the fundus, VUNO Med®-Fundus AI™ is approved as a Class III medical device by the Ministry of Food and Drug Safety. VUNO Med®-Fundus AI™ is the first ev
In the face of the COVID-19 pandemic raging around the globe, VUNO, a member company of the Born2Global Centre, has decided to move quickly by joining the global coalition to help address some critical issues facing the international healthcare community